应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BBNX Beta Bionics, Inc.
休市中 05-01 16:00:00 EDT
10.29
+0.09
+0.88%
盘后
10.29
+0.00
0.00%
16:37 EDT
最高
10.54
最低
10.16
成交量
46.67万
今开
10.24
昨收
10.20
日振幅
3.73%
总市值
4.59亿
流通市值
2.50亿
总股本
4,456万
成交额
481.59万
换手率
1.92%
流通股本
2,429万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Beta Bionics推出Bionic Reports™中的Bionic Insights™功能——变革临床医生理解与优化糖尿病护理的方式
美股速递 · 03-31
Beta Bionics推出Bionic Reports™中的Bionic Insights™功能——变革临床医生理解与优化糖尿病护理的方式
Beta Bionics, Inc.2025财年实现净利润-73.20百万美元,同比减少33.67%
市场透视 · 02-21
Beta Bionics, Inc.2025财年实现净利润-73.20百万美元,同比减少33.67%
Beta Bionics, Inc.盘中异动 大幅上涨5.20%
市场透视 · 02-13
Beta Bionics, Inc.盘中异动 大幅上涨5.20%
Beta Bionics, Inc.盘中异动 快速下挫5.05%报17.50美元
市场透视 · 01-21
Beta Bionics, Inc.盘中异动 快速下挫5.05%报17.50美元
Beta Bionics, Inc.盘中异动 临近午盘股价大跌5.10%报16.39美元
市场透视 · 01-15
Beta Bionics, Inc.盘中异动 临近午盘股价大跌5.10%报16.39美元
Beta Bionics, Inc.盘中异动 下午盘急速下跌5.01%报26.75美元
市场透视 · 2025-11-14
Beta Bionics, Inc.盘中异动 下午盘急速下跌5.01%报26.75美元
Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。
Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。
Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。
Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。
加载更多
公司概况
公司名称:
Beta Bionics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立,并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司,从事创新解决方案的设计、开发和商业化,通过利用先进的自适应闭环算法简化和改善其疾病的治疗,提高胰岛素需求糖尿病患者的健康和生活质量。
发行价格:
--
{"stockData":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":10.29,"timestamp":1777665600000,"preClose":10.2,"halted":0,"volume":466650,"hourTrading":{"tag":"盘后","latestPrice":10.29,"preClose":10.29,"latestTime":"16:37 EDT","volume":2920,"amount":30045,"timestamp":1777667852199,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008823529411764692,"floatShares":24289699,"shares":44561695,"eps":-1.51137,"marketStatus":"休市中","change":0.09,"latestTime":"05-01 16:00:00 EDT","open":10.24,"high":10.54,"low":10.16,"amount":4815877.93155,"amplitude":0.037255,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.51137,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":7,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":10.2,"preHourTrading":{"tag":"盘前","latestPrice":9.9,"preClose":10.2,"latestTime":"07:30 EDT","volume":2,"amount":19.849998,"timestamp":1777635036767,"change":-0.3,"changeRate":-0.029412,"amplitude":0.004902},"postHourTrading":{"tag":"盘后","latestPrice":10.29,"preClose":10.29,"latestTime":"16:37 EDT","volume":2920,"amount":30045,"timestamp":1777667852199,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5542208480539317,"impliedVol":1.0351,"impliedVolPercentile":0.5897},"requestUrl":"/m/hq/s/BBNX","defaultTab":"news","newsList":[{"id":"1113459701","title":"Beta Bionics推出Bionic Reports™中的Bionic Insights™功能——变革临床医生理解与优化糖尿病护理的方式","url":"https://stock-news.laohu8.com/highlight/detail?id=1113459701","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113459701?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:02","pubTimestamp":1774951345,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. (BBNX) 近日宣布,在其Bionic Reports™平台中全新引入了Bionic Insights™功能。这一创新工具旨在彻底改变临床医生理解和优化糖尿病护理的方式,通过提供更深入、更智能的数据分析,帮助医疗专业人员制定更精准的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613909762","title":"Beta Bionics, Inc.2025财年实现净利润-73.20百万美元,同比减少33.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613909762","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613909762?lang=zh_cn&edition=full","pubTime":"2026-02-21 00:00","pubTimestamp":1771603256,"startTime":"0","endTime":"0","summary":"2月21日,Beta Bionics, Inc.公布财报,公告显示公司2025财年净利润为-73.20百万美元,同比减少33.67%;其中营业收入为1.00亿美元,同比增加53.56%,每股基本收益为-1.81美元。从资产负债表来看,Beta Bionics, Inc.总负债39.59百万美元,其中短期债务1.94百万美元,资产负债比为0.09,流动比率为0.09。机构评级:截至2026年2月21日,当前有12家机构对Beta Bionics, Inc.目标价做出预测,其中目标均价为23.42美元,其中最低目标价为14.00美元,最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221000111a70dc7f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221000111a70dc7f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611411634","title":"Beta Bionics, Inc.盘中异动 大幅上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611411634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611411634?lang=zh_cn&edition=full","pubTime":"2026-02-13 22:59","pubTimestamp":1770994780,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日22时59分,Beta Bionics, Inc.股票出现波动,股价大幅上涨5.20%。Beta Bionics, Inc.股票所在的医疗器械行业中,整体涨幅为0.99%。其相关个股中,Catheter Precision, Inc.、Avita Medical, Inc.、德康医疗涨幅较大,Catheter Precision, Inc.、Envue Medical, Inc.、Bluejay Diagnostics, Inc.较为活跃,换手率分别为46.06%、15.10%、5.50%,振幅较大的相关个股有Catheter Precision, Inc.、Avita Medical, Inc.、Adagio Medical Holdings, Inc,振幅分别为14.95%、14.55%、13.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021322594097a620db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021322594097a620db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605480793","title":"Beta Bionics, Inc.盘中异动 快速下挫5.05%报17.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605480793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605480793?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:59","pubTimestamp":1769007564,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日22时59分,Beta Bionics, Inc.股票出现波动,股价急速跳水5.05%。Beta Bionics, Inc.股票所在的医疗器械行业中,整体涨幅为0.54%。Beta Bionics, Inc.公司简介:Beta Bionics Inc 是一家商业化阶段的医疗器械公司,致力于设计、开发和商业化解决方案,通过利用自适应闭环算法简化和改善其疾病治疗,改善需要胰岛素的糖尿病患者 的健康和生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012122592497a2cf1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012122592497a2cf1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603641539","title":"Beta Bionics, Inc.盘中异动 临近午盘股价大跌5.10%报16.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603641539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603641539?lang=zh_cn&edition=full","pubTime":"2026-01-15 00:46","pubTimestamp":1768409202,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日00时46分,Beta Bionics, Inc.股票出现波动,股价快速下跌5.10%。截至发稿,该股报16.39美元/股,成交量51.9876万股,换手率1.18%,振幅4.92%。Beta Bionics, Inc.股票所在的医疗器械行业中,整体跌幅为0.17%。Beta Bionics, Inc.公司简介:Beta Bionics Inc 是一家商业化阶段的医疗器械公司,致力于设计、开发和商业化解决方案,通过利用自适应闭环算法简化和改善其疾病治疗,改善需要胰岛素的糖尿病患者 的健康和生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011500464297a1d55d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011500464297a1d55d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583183505","title":"Beta Bionics, Inc.盘中异动 下午盘急速下跌5.01%报26.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583183505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583183505?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:17","pubTimestamp":1763057853,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日02时17分,Beta Bionics, Inc.股票出现波动,股价急速跳水5.01%。截至发稿,该股报26.75美元/股,成交量18.1097万股,换手率0.41%,振幅8.43%。Beta Bionics, Inc.股票所在的医疗器械行业中,整体涨幅为0.56%。Beta Bionics, Inc.公司简介:Beta Bionics Inc 是一家商业化阶段的医疗器械公司,致力于设计、开发和商业化解决方案,通过利用自适应闭环算法简化和改善其疾病治疗,改善需要胰岛素的糖尿病患者 的健康和生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114021733a6f798eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114021733a6f798eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513777845","title":"Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513777845","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513777845?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:21","pubTimestamp":1740410466,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24232148353170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722329","title":"Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722329?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:22","pubTimestamp":1740406925,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24222248352806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513272995","title":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272995","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513272995?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:21","pubTimestamp":1740403316,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24212148352460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513723151","title":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723151","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513723151?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:20","pubTimestamp":1740399654,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24202048351403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.betabionics.com","stockEarnings":[{"period":"1week","weight":-0.0788},{"period":"1month","weight":0.028},{"period":"3month","weight":-0.256},{"period":"6month","weight":-0.622},{"period":"1year","weight":-0.0763},{"period":"ytd","weight":-0.6623}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立,并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司,从事创新解决方案的设计、开发和商业化,通过利用先进的自适应闭环算法简化和改善其疾病的治疗,提高胰岛素需求糖尿病患者的健康和生活质量。","exchange":"NASDAQ","name":"Beta Bionics, Inc.","nameEN":"Beta Bionics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beta Bionics, Inc.,BBNX,Beta Bionics, Inc.股票,Beta Bionics, Inc.股票老虎,Beta Bionics, Inc.股票老虎国际,Beta Bionics, Inc.行情,Beta Bionics, Inc.股票行情,Beta Bionics, Inc.股价,Beta Bionics, Inc.股市,Beta Bionics, Inc.股票价格,Beta Bionics, Inc.股票交易,Beta Bionics, Inc.股票购买,Beta Bionics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}